Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2011 Jul 6;306(1):53-61.
doi: 10.1001/jama.2011.916.

Appropriateness of percutaneous coronary intervention

Affiliations
Multicenter Study

Appropriateness of percutaneous coronary intervention

Paul S Chan et al. JAMA. .

Abstract

Context: Despite the widespread use of percutaneous coronary intervention (PCI), the appropriateness of these procedures in contemporary practice is unknown.

Objective: To assess the appropriateness of PCI in the United States.

Design, setting, and patients: Multicenter, prospective study of patients within the National Cardiovascular Data Registry undergoing PCI between July 1, 2009, and September 30, 2010, at 1091 US hospitals. The appropriateness of PCI was adjudicated using the appropriate use criteria for coronary revascularization. Results were stratified by whether the procedure was performed for an acute (ST-segment elevation myocardial infarction, non-ST-segment elevation myocardial infarction, or unstable angina with high-risk features) or nonacute indication.

Main outcome measures: Proportion of acute and nonacute PCIs classified as appropriate, uncertain, or inappropriate; extent of hospital-level variation in inappropriate procedures.

Results: Of 500,154 PCIs, 355,417 (71.1%) were for acute indications (ST-segment elevation myocardial infarction, 103,245 [20.6%]; non-ST-segment elevation myocardial infarction, 105,708 [21.1%]; high-risk unstable angina, 146,464 [29.3%]), and 144,737 (28.9%) for nonacute indications. For acute indications, 350,469 PCIs (98.6%) were classified as appropriate, 1055 (0.3%) as uncertain, and 3893 (1.1%) as inappropriate. For nonacute indications, 72,911 PCIs (50.4%) were classified as appropriate, 54,988 (38.0%) as uncertain, and 16,838 (11.6%) as inappropriate. The majority of inappropriate PCIs for nonacute indications were performed in patients with no angina (53.8%), low-risk ischemia on noninvasive stress testing (71.6%), or suboptimal (≤1 medication) antianginal therapy (95.8%). Furthermore, although variation in the proportion of inappropriate PCI across hospitals was minimal for acute procedures, there was substantial hospital variation for nonacute procedures (median hospital rate for inappropriate PCI, 10.8%; interquartile range, 6.0%-16.7%).

Conclusions: In this large contemporary US cohort, nearly all acute PCIs were classified as appropriate. For nonacute indications, however, 12% were classified as inappropriate, with substantial variation across hospitals.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Chan reported receiving support from a Career Development Grant Award (K23HL102224) from the National Heart, Lung, and Blood Institute (NHLBI) to examine the appropriateness of percutaneous coronary intervention in the United States. Dr Spertus reported having a contract from the American College of Cardiology (ACC) to analyze National Cardiovascular Data Registry (NCDR) data. Drs Brindis, Masoudi, and Rumsfeld reported receiving salary support from the ACC. No other authors reported disclosures.

Figures

Figure 1
Figure 1
PCI Appropriateness Study Cohort CT indicates computed tomography; NCDR, National Cardiovascular Data Registry; PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction. aIncluded as part of sensitivity analyses.
Figure 2
Figure 2
Variation in Hospital Rates of Inappropriate Percutaneous Coronary Interventions for Nonacute Indications A, Distribution of hospital rates of inappropriate percutaneous coronary interventions (PCIs) for non-acute indications. Only hospitals with at least 10 non-acute PCIs annually were included (499 676 PCIs, 978 sites); 478 PCIs from 113 low-volume hospitals were excluded. The distribution of hospital rates was similar when analyses were restricted to hospitals with a minimum of 200 nonacute PCIs annually (see “Methods”). B, Relationship between a hospital’s nonacute PCI volume and its rate of inappropriate PCI in the nonacute setting.

Comment in

References

    1. Cadet J. AHA adjusts angioplasty stats to lower annual figure. [Accessed January 20, 2011];Cardiovascular Business Web site. 2010 December 19; http://www.cardiovascularbusiness.com/index.php?option=com_articles&arti....
    1. Mahoney EM, Wang K, Arnold SV, et al. Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel—Thrombolysis in Myocardial Infarction TRITON-TIMI 38. Circulation. 2010;121(1):71–79. - PubMed
    1. Boden WE, O’Rourke RA, Teo KK, et al. COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503–1516. - PubMed
    1. Hilborne LH, Leape LL, Bernstein SJ, et al. The appropriateness of use of percutaneous transluminal coronary angioplasty in New York State. JAMA. 1993;269(6):761–765. - PubMed
    1. Yim J, Khang YH, Oh BH, Kim YI, Kim CY. The appropriateness of percutaneous transluminal coronary angioplasty in Korea. Int J Cardiol. 2004;95(2–3):199–205. - PubMed

Publication types

MeSH terms